Related Experiment Videos
Novel gene delivery to liver cells using engineered virosomes
1Department of Biochemistry, University of Delhi South Campus, New Delhi, India.
FEBS Letters
|March 10, 1997
Summary
Sendai viral F-virosomes efficiently deliver foreign genes into human hepatoblastoma cells (HepG2). This membrane fusion-mediated gene delivery method, using viral envelope glycoproteins, shows higher CAT gene expression than other methods.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- Gene delivery is crucial for research and therapeutics.
- Current methods like Lipofectin have limitations.
- Viral envelope glycoproteins offer potential for targeted delivery.
Purpose of the Study:
- To evaluate F-virosomes as gene delivery vehicles.
- To assess gene delivery efficiency into HepG2 cells.
- To compare F-virosome delivery with existing methods.
Main Methods:
- Reconstituted Sendai viral envelopes (F-virosomes) were created.
- Chloramphenicol acetyl transferase (CAT) gene was delivered.
- Gene entry and expression in HepG2 cells were quantified.
- Delivery efficiency was compared to Lipofectin and proteo-liposomes.
Main Results:
- F-virosomes efficiently delivered the CAT gene into HepG2 cells.
- Membrane fusion-mediated entry was confirmed.
- CAT gene expression was dose-dependent and time-dependent.
- F-virosome delivery resulted in significantly higher CAT expression than controls.
Conclusions:
- F-virosomes are effective vehicles for targeted gene delivery.
- Viral envelope glycoprotein-mediated fusion enhances gene transfer.
- This method holds promise for in vitro and in vivo gene therapy applications.